June 19 (Reuters) - Emerald Health Therapeutics Inc EMH.V :
* EMERALD HEALTH THERAPEUTICS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* EMERALD HEALTH- NET SALES OF $2.9M INCREASED 36% IN QUARTER
* EMERALD HEALTH- Q1 NET LOSS OF $4.9 MILLION INCLUDES $2.0 MILLION LOSS ON DILUTION OF JV OWNERSHIP, $1.1M INVENTORY WRITE-DOWN
* EMERALD HEALTH- DUE DILIGENCE PROCESS OF AGREEMENT WITH SIGMA ANALYTICAL SERVICES INC HAS BEEN DELAYED DUE TO COVID-19